ArticleJournal of global health2026
Diagnostic accuracy of a molecular-based point-of-care test for rapid detection of respiratory syncytial virus in children admitted to high-dependency care in Nepal.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessing the cost of illness of RSV and non-RSV acute respiratory infections in Nepali children.Journal of global health · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: Rapid respiratory syncytial virus (RSV) diagnostics are largely unavailable in low-resource settings. We compared the diagnostic accuracy of a molecular-based point-of-care test (POCT) with standard reverse transcription polymerase chain reaction (RT-PCR) in children admitted to high-dependency care. Methods: We analysed data from a larger study (RSV GOLD - ICU Network study) in two Nepali tertiary hospitals over two respiratory seasons. Children aged ≥4 days and <2 years admitted to high-dependency units were tested for RSV using POCT at admission. We calculated sensitivity, specificity, and predictive values of POCT against laboratory RT-PCR on stored samples as the gold standard. Results: We analysed 124 randomly selected stored samples, of whom 70 (56.5%) tested positive with POCT and 74 (59.7%) with RT-PCR. The median cycle threshold (CT) value was 29.1 (interquartile range = 25.1-33.4). All cases with false-negative POCT had low viral loads (CT value >31). The sensitivity (93.2%; 95% confidence interval (CI) = 86.0, 97.5), specificity (98.0%; 95% CI = 91.5, 99.9), positive predictive values (98.6%; 95% CI = 93.9, 99.9), and negative predictive values (90.7%; 95% CI = 81.1, 96.6) of POCT for RSV infection were all satisfactory. Conclusions: We conducted the first prospective study showing excellent accuracy of molecular RSV POCT in a poor resource setting. Affordable molecular-based POCT in resource-constrained settings can improve care of children with acute respiratory infections and strengthen surveillance for vaccine effectiveness during rollout of RSV interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.